(See Figure 2 for a timeline of key activities associated with the GLP-1 coverage demonstrations.) Medicare coverage of GLP-1s for obesity begins in July 2026 through the Medicare GLP-1 Bridge and will be extended through the end of 2027 CMS will provide Part D beneficiaries with coverage of select GLP-1s for obesity from July 1, 2026 to December 31, 2027 (originally December 31, 2026) through the Medicare GLP-1 Bridge, which is a short-term demonstration established using Section 402 demonstration authority
RELATED: The Trampoline Workout You Remember Reframed for the Adult Body Bifidobacterium lactis BB-12 BB-12 has been found to improve stool frequency and reduce abdominal discomfort
Mild redness, stinging, and small bruising are common and typically resolve within 24-48 hours
Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, et al
News release
Compared to similar medications, Ozempic has delivered superior weight loss results in numerous clinical trials
